Back
 SS  Vol.4 No.11 , November 2013
Pancreaticoduodenectomy for Pancreatic Metastases of Malignant Fibrous Histiocytoma
Abstract: Unlike primary pancreatic carcinoma, metastases to the pancreas are rare and their resection may be performed as a palliative treatment due to poorly defined outcome. We herein present an extremely rare case of pancreatic metastases of malignant fibrous histiocytoma (MFH) undergoing pancreaticoduodenectomy with tumor-free survival within postoperative 35-month follow-up. Pancreatic resection for metastatic MFH to the pancreas should be considered in selected patients. Long-term survival or good palliation may be achieved.
Cite this paper: J. Zhu, H. Cai and D. Sun, "Pancreaticoduodenectomy for Pancreatic Metastases of Malignant Fibrous Histiocytoma," Surgical Science, Vol. 4 No. 11, 2013, pp. 506-508. doi: 10.4236/ss.2013.411098.
References

[1]   S. Reddy and C. L. Wolfgang, “The Role of Surgery in the Management of Isolated Metastases to the Pancreas,” The Lancet Oncology, Vol. 10, No. 3, 2009, pp. 287-293. http://dx.doi.org/10.1016/ S1470-2045(09)70065-8

[2]   C. Sperti, C. Pasquali, G. Liessi, L. Pinciroli, G. Decet and S. Pedrazzoli, “Pancreatic Resection for Metastatic Tumors to the Pancreas,” Journal of Surgical Oncology, Vol. 83, No. 3, 2003, pp. 161-166. http://dx.doi.org/10.1002/jso.10262

[3]   Y. Shinagawa, T. Suzuki, Y. Hamanaka, K. Nishihara and M. Takahasi, “Solitary Pancreatic Metastasis of Malignant Fibrous Histiocytoma Treated by Distal Pancreatectomy,” Pancreas, Vol. 7, 1992, pp. 726-730. http://dx.doi.org/10.1097/00006676-199211000-00015

[4]   T. Akatsu, M. Shimazu, T. Morii, H. Morioka, H. Yabe and M. Kitajima, “Pancreatic Metastasis from Musculoskeletal Sarcoma: A Case Report with Malignant Fibrous Histiocytoma and Review of the Literature,” Digestive Diseases and Sciences, Vol. 52, No. 8, 2007, pp. 1958-1963.
http://dx.doi.org/10.1007/s10620-006-9424-6

[5]   M. M. Ho, T. J. Howard and K. D. Lillemoe, “Can Pancreaticoduodenectomy Be Used to Palliate Selective Metastatic Malignancies? Case Report of Malignant Fibrous Histiocytoma,” Journal of Gastrointestinal Surgery, Vol. 9, No. 7, 2005, pp. 934-937. http://dx.doi.org/10.1016/j.gassur. 2005.04.014

[6]   G. C. Sotiropoulos, H. Lang, C. Liu, E. I. Brokalaki, E. Molmenti and C. E. Broelsch, “Surgical Treatment of Pancreatic Metastases of Renal Cell Carcinoma,” JOP: Journal of the Pancreas, Vol. 6, No. 4, 2005, pp. 339-343.

[7]   H. Medina-Franco, N. B. Halpern and J. S. Aldrete, “Pancreaticoduodenectomy for Metastatic Tumors to the Periampullary Region,” Journal of Gastrointestinal Surgery, Vol. 3, No. 2, 1999, pp. 119-122. http://dx.doi.org/10.1016/S1091-255X(99)80019-5

[8]   E. Nakamura, M. Shimizu, T. Itoh and T. Manabe, “Secondary Tumors of the Pancreas: Clinicopathological Study of 103 Autopsy Cases of Japanese Patients,” Pathology International, Vol. 51, No. 9, 2001, pp. 686-690. http://dx.doi.org/10.1046/j.1440-1827.2001.01258.x

[9]   T. Belagyi, P. Zsoldos, R. Makay, A. Issekutz and A. Olah, “Multiorgan Resection (Including the Pancreas) for Metastasis of Cutaneous Malignant Melanoma,” JOP: Journal of the Pancreas, Vol. 7, No. 2, 2006, pp. 234-240.

[10]   J. M. Alamo, F. Pareja, M. A. Gomez, I. Alarcon, C. Bernardos, L. Barrera, et al., “Obstructive Jaundice Secondary to Pancreatic Metastases of a Soft-Tissue Sarcoma,” Revista Espanola de Enfermedades Digestivas, Vol. 99, No. 9, 2007, pp. 557-559.

[11]   L. Ozzello, A. P. Stout and M. R. Murray, “Cultural Characteristics of Malignant Histiocytomas and Fibrous Xanthomas,” Cancer, Vol. 16, No. 3, 1963, pp. 331-344. http://dx.doi.org/10.1002/1097-0142(196303)16:3<331::AID-CNCR2820160307>3.0.CO;2-F

[12]   S. Crippa, C. Angelini, C. Mussi, C. Bonardi, F. Romano, P. Sartori, et al., “Surgical Treatment of Metastatic Tumors to the Pancreas: A Single Center Experience and Review of the Literature,” World Journal of Surgery, Vol. 30, No. 8, 2006, pp. 1536-1542. http://dx.doi.org/10.1007/s00268-005-0464-4

[13]   S. Eidt, M. Jergas, R. Schmidt and M. Siedek, “Metastasis to the Pancreas—An Indication for Pancreatic Resection?” Langenbeck’s Archives of Surgery, Vol. 392, No. 5, 2007, pp. 539-542. http://dx.doi.org/10.1007/s00423-007-0148-7

[14]   J. C. Gutierrez, E. A. Perez, D. Franceschi, F. L. Moffat, Jr., A. S. Livingstone and L. G. Koniaris, “Outcomes for Soft-Tissue Sarcoma in 8249 Cases from a Large State Cancer Registry,” The Journal of Surgical Research, Vol. 141, No. 1, 2007, pp. 105-114. http://dx.doi.org/10.1016/j.jss.2007.02.026

[15]   D. Krikelis and I. Judson, “Role of Chemotherapy in the Management of Soft Tissue Sarcomas,” Expert Review of Anticancer Therapy, Vol. 10, No. 2, 2010, pp. 249-260. http://dx.doi.org/ 10.1586/era.09.176

[16]   A. N. van Geel, U. Pastorino, K. W. Jauch, I. R. Judson, F. van Coevorden, J. M. Buesa, et al., “Surgical Treatment of Lung Metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Study of 255 Patients,” Cancer, Vol. 77, No. 4, 1996, pp. 675-682. http://dx.doi.org/10.1002/(SICI)1097-0142(19960215)77:4<675::AID-CNCR13>3.0.CO;2-Y

 
 
Top